Rheon Medical is revolutionizing the surgical treatment of glaucoma
EPFL spin-off Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe. The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2020 and just received the U.S. FDA’s Breakthrough Device Designation for its technology.